Jonathon Cohen MD MS
@jonathonbcohen
Professor and Co-director of Lymphoma Program @WinshipAtEmory / opinions = my own
ID: 4404759081
https://winshipcancer.emory.edu/jonathon-b-cohen 07-12-2015 12:37:49
313 Tweet
1,1K Takipçi
80 Takip Edilen
The phase 1 portion of the open-label study was completed in November 2019 and reported that dose level 2 (4 mg of ixazomib plus 560 mg of ibrutinib) should be used as the recommended phase 2 dose in the study. Jonathon Cohen MD MS Winship Cancer Institute of Emory University #lymsm ow.ly/8Ezk50EQPEg
A fantastic achievement and collaboration for several trainees with bright futures! Thanks to Carrie Thompson, MD and @BKLinkIowa for supporting this work.
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma ASH Blood Advances ashpublications.org/bloodadvances/… Nice work by UVA Health Dr Portell and then fellow now Winship Cancer Institute of Emory University faculty Dr Orellana-Noia. #lymsm
Kudos to NYU Langone Health Medical College of Wisconsin and UVA Cancer Center for enrolling patients to PrE0404, our #clinicaltrial for patients with relapsed mantle cell #lymphoma. Learn more about the study: bit.ly/pre0404 #MCL #lymsm cc: Jonathon Cohen MD MS Mehdi Hamadani, MD
National 2022 Lymphoma Research Foundation rounds is just a day away! Join me, Jonathon Cohen MD MS, Paul Hampel other fellow physicians on Feb 10th to learn more about the treatment of lymphoma in interactive case presentations- more info and register at lymphoma.org/nationalrounds! Mayo Clinic Comprehensive Cancer Center
Calling all #hemefellows and #younginvestigators: apply now for the Next Wave Academy! Don't miss this opportunity for #mentorship with renowned #CLL and #NHL thought leaders. Click here to apply: loom.ly/ya4PboA. John P. Leonard, MD Matthew Davids, MD, MMSc Jonathon Cohen MD MS
Winship hematologist Jonathon Cohen, MD, MS, a graduate of Emory College of Arts & Sciences, has been named a 2022 recipient of the Emory Alumni Association’s 40 Under Forty award. Congratulations Jonathon Cohen MD MS! ➡️ fal.cn/3tIPC
Winship hematologist Jason Romancik, MD, has received a grant from Cures Within Reach (Cures Within Reach) to lead a new clinical repurposing trial, “Combining approved drugs for alcoholism and cancer to treat diffuse large B-cell #lymphoma.” ➡️ fal.cn/3u7RT
In this feature, Jonathon Cohen, MD, MS, Jonathon Cohen MD MS, of Winship Cancer Institute of Emory University, discusses how he came to focus on lymphoma, as well as current research, pressing questions, and potentially paradigm-shifting data in MCL. Society of Hematologic Oncology (SOHO) buff.ly/3XqH9PK
Another day of snow and amazing talks from our faculty! Starting us off, Jonathon Cohen MD MS reminds us of the importance if multi-institution research collaboration to shed light on rare tumors. #DAVAWhistler
Meet Dr. Jonathon Cohen, a trailblazer co-directing lymphoma research Winship Cancer Institute of Emory University and leader at the IMPACT program, which brings treatment trials directly to #BloodCancer patients in their communities. ⚖️🩸 Learn more about Dr. Cohen’s progress 👉 bit.ly/47In0uh
